Development of efficient process for isolation, propagation and differentiation induction of normal human hepatic stem cells and its application to artificial liver
Development of efficient process for isolation, propagation and differentiation induction of normal human hepatic stem cells and its application to artificial liver
批准号:
15560681
负责人:
MATSUSHITA Taku
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
1、正常人肝干细胞在增殖过程中转化及其预防的研究如果正常人肝干细胞(肝母细胞)在增殖过程中转化,这些细胞就不能应用于再生医学和人工肝。事实上,干细胞和转化的肿瘤细胞具有相似的特性和制造者。本研究以肝细胞的临床肿瘤生成因子PIVKA-II(异常凝血酶原)为制造因子,建立了肝干细胞(肝母细胞)转化的检测方法。我们通过PIVKA-II实验发现,人胎肝细胞包括肝母细胞在第8代繁殖时开始转化。结果表明,丁酸钠对人胎肝细胞成肝细胞的诱导作用与丁酸钠浓度有关。还发现维生素K对人胎儿肝细胞的转化有预防作用。2、肝母细胞高密度培养基质材料的研究。为了开发人成肝细胞人工肝模块,有必要对培养底物的材料特性进行高密度培养、功能表达和人成肝细胞转化的预防研究。在本研究中,我们检测了几种培养基质。大孔siran材料更适合高密度培养。多孔羟基磷灰石更有利于细胞色素P450活性的表达。
英文摘要
1, Studies on transformation of normal human hepatic stem cells in propagation process and its preventionIf the normal human hepatic stem cells (hepatoblast) transform in propagation process, these cells can not be applicable to regenerative medicine and artificial liver. In fact, the stem cells and transformed tumor cells have similar characteristics and makers. In this research, we developed the examination method for the transformation of hepatic stem cells (hepatoblast) using PIVKA-II (abnormal prothrombin) as a maker, which is clinical tumor maker of hepatocytes. We indicated that human fetal hepatocytes including hepatoblasts started to transform at the8th passage of propagation by using PIVKA-II assay. And we also indicated that induction of hepatoblast from human fetal hepatocytes teated with Sodium butyrate, caused the transformation depended on the concentration of sodium butyrate. It was also found that Vitamin K has prevention effect of the transformation of human fetal heptaocytes.2,Studies on the materials of culture substrate for high density culture of hepatoblast.For development of artificial liver module using human hepatoblast, it is necessary to study on material characteristics of culture substrate for high density culture, functional expression and prevention of transformation of human hepatoblast. In this research, we examined several culture substrates. Macroporous siran material was better for high density culture. And porous hydroxyapatite was better for cytochrome P450 activity expression of hepatoblast.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
人工肝臓開発のための細胞源の検討-肝幹細胞の利用とがん化(形質転換)の抑制-
人工肝开发的细胞来源的思考 - 肝干细胞的利用和癌变(转化)的抑制 -
DOI:
--
发表时间:
2004
期刊:
化学工学会沖縄大会研究発表講演要旨集
影响因子:
--
作者:
[Y Matsumoto, Y Kadota, Y Matsumoto, Y Kadota, Y Matsumoto, 松下 琢]
通讯作者:
松下 琢
正常ヒト肝幹細胞を用いた人工肝臓開発のための基礎的研究
利用正常人肝干细胞开发人工肝的基础研究
DOI:
--
发表时间:
2004
期刊:
化学工学会秋田大会研究発表講演要旨集
影响因子:
--
作者:
[Y Matsumoto, Y Kadota, Y Matsumoto, Y Kadota, Y Matsumoto, 松下 琢, 松下 琢]
通讯作者:
松下 琢
T.Matsushita: "Spheroid formation and functional restoration of human fetal hepatocytes on poly-amino acid-coated dishes after serial proliferation"Cytotechnology. 42巻2号. 57-66 (2003)
T.Matsushita:“连续增殖后聚氨基酸包被培养皿上人胎儿肝细胞的球体形成和功能恢复”《细胞技术》第 42 卷,第 2. 57-66 期(2003 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Novel mechanism of hybrid liposomes-induce apoptosis in human tumor cells.
混合脂质体诱导人类肿瘤细胞凋亡的新机制。
DOI:
--
发表时间:
2005
期刊:
International Journal of Cancer 115巻(In press)
影响因子:
--
作者:
[Y Matsumoto, Y Kadota, Y Matsumoto, Y Kadota, Y Matsumoto]
通讯作者:
Y Matsumoto
The basic research for artificial liver development using normal human hepatic stem cells.
利用正常人肝干细胞开发人工肝的基础研究。
DOI:
--
发表时间:
2004
期刊:
Proceedings of Akita meeting of chemical engineering society of Japan. SA218
影响因子:
--
作者:
[Y Matsumoto, Y Kadota, Y Matsumoto, Y Kadota, Y Matsumoto, 松下 琢, 松下 琢, 清田 章文, T Matsushita, T Matsushita]
通讯作者:
T Matsushita
共 12 条
Studies on the evaluation method for chemical compound toxicity to human hepatocytes by using hollow fiber type three dimensional culture module
-
批准号:26420804
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2014
-
负责人:MATSUSHITA Taku
-
依托单位:
Estimating removal of unculturable waterborne virus during drinking water treatment by using VLPs
-
批准号:24360211
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.82万
-
财政年份:2012
-
负责人:MATSUSHITA Taku
-
依托单位:
Investigation on quantum state of one-dimensional helium-3 fluid formed in nanochannels
-
批准号:23540404
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:MATSUSHITA Taku
-
依托单位:
Expression of drug resisitance phenomena of cancer cells by 3D-culture and its application to development of new assay system for anti-cancer drugs
-
批准号:23560951
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:MATSUSHITA Taku
-
依托单位:
Evaluating removal of norovirus during drinking water treatment by using recombinant virus-like particles
-
批准号:21686049
-
项目类别:Grant-in-Aid for Young Scientists (A)
-
资助金额:$16.31万
-
财政年份:2009
-
负责人:MATSUSHITA Taku
-
依托单位:
Development of a new culture process to prevent an oncogenic transformation of the stem cells
-
批准号:19560782
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:MATSUSHITA Taku
-
依托单位:
Removal of norovirus during drinking water treatment: Application of recombinant virus-like particles
-
批准号:19760368
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.42万
-
财政年份:2007
-
负责人:MATSUSHITA Taku
-
依托单位:
Development of a culture process for preventing transformation of normal hepatic stem cells and its application to regenerative medicine
-
批准号:17560693
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:MATSUSHITA Taku
-
依托单位:
Development of ultra-small scale screening system using Tisgue engineering for human genomics based drug discovery
-
批准号:12650790
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2000
-
负责人:MATSUSHITA Taku
-
依托单位:
Optimal designing of animal cell bioreactors by three-dimensional flow simulation using super-computer
-
批准号:05650804
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1993
-
负责人:MATSUSHITA Taku
-
依托单位:
海外基金